These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

884 related items for PubMed ID: 17561129

  • 1. The impact factors on prognosis of patients with pT3 upper urinary tract transitional cell carcinoma.
    Wu CF, Pang ST, Chen CS, Chuang CK, Chen Y, Lin PY.
    J Urol; 2007 Aug; 178(2):446-50, dicussion 450. PubMed ID: 17561129
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Lymphovascular invasion and pT stage are prognostic factors in patients treated with radical nephroureterectomy for localized upper urinary tract transitional cell carcinoma.
    Kim DS, Lee YH, Cho KS, Cho NH, Chung BH, Hong SJ.
    Urology; 2010 Feb; 75(2):328-32. PubMed ID: 20018349
    [Abstract] [Full Text] [Related]

  • 5. Prognostic value of lymphovascular invasion in transitional cell carcinoma of upper urinary tract.
    Hong B, Park S, Hong JH, Kim CS, Ro JY, Ahn H.
    Urology; 2005 Apr; 65(4):692-6. PubMed ID: 15833510
    [Abstract] [Full Text] [Related]

  • 6. Postoperative radiation therapy in 26 patients with invasive transitional cell carcinoma of the upper urinary tract: no impact on survival?
    Maulard-Durdux C, Dufour B, Hennequin C, Chrétien Y, Vignes B, Droz D, Delanian S, Housset M.
    J Urol; 1996 Jan; 155(1):115-7. PubMed ID: 7490805
    [Abstract] [Full Text] [Related]

  • 7. Prognostic impact of extensive parenchymal invasion pattern in pT3 renal pelvic transitional cell carcinoma.
    Yoshimura K, Arai Y, Fujimoto H, Nishiyama H, Ogura K, Okino T, Ogawa O.
    Cancer; 2002 Jun 15; 94(12):3150-6. PubMed ID: 12115347
    [Abstract] [Full Text] [Related]

  • 8. Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically.
    Saito K, Kawakami S, Fujii Y, Sakura M, Masuda H, Kihara K.
    J Urol; 2007 Dec 15; 178(6):2291-6; discussion 2296. PubMed ID: 17936818
    [Abstract] [Full Text] [Related]

  • 9. Prognostic significance of bladder tumor history and tumor location in upper tract transitional cell carcinoma.
    Akdogan B, Dogan HS, Eskicorapci SY, Sahin A, Erkan I, Ozen H.
    J Urol; 2006 Jul 15; 176(1):48-52. PubMed ID: 16753365
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Prognostic implication of morphometric stromal parameters of renal pelvis and ureteral transitional cell carcinomas].
    Al'-Shukri CKh, Rybakova MG, Makovskaia AI, Tiurin AG, Kozlov VV, Ageev MN, Korneev IA.
    Urologiia; 2004 Jul 15; (3):10-4. PubMed ID: 15199806
    [Abstract] [Full Text] [Related]

  • 12. Location of the primary tumor is not an independent predictor of cancer specific mortality in patients with upper urinary tract urothelial carcinoma.
    Isbarn H, Jeldres C, Shariat SF, Liberman D, Sun M, Lughezzani G, Widmer H, Arjane P, Pharand D, Fisch M, Graefen M, Montorsi F, Perrotte P, Karakiewicz PI.
    J Urol; 2009 Nov 15; 182(5):2177-81. PubMed ID: 19758662
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The role of lymphovascular invasion in predicting the prognosis of clinically localized upper tract urothelial carcinoma (pT1-3cN0M0).
    Lin WC, Hu FC, Chung SD, Chueh SC, Pu YS, Huang KH.
    J Urol; 2008 Sep 15; 180(3):879-84; discussion 884-5. PubMed ID: 18635224
    [Abstract] [Full Text] [Related]

  • 15. Laparoscopic radical nephroureterectomy: a multicenter analysis in Japan.
    Kamihira O, Hattori R, Yamaguchi A, Kawa G, Ogawa O, Habuchi T, Kawauchi A, Uozumi J, Yokoi S, Tsujihata M, Hasui Y, Miyakoda K, Tada H, Ono Y, Naito S.
    Eur Urol; 2009 Jun 15; 55(6):1397-407. PubMed ID: 19299072
    [Abstract] [Full Text] [Related]

  • 16. Expression of metalloproteinase-2, metalloproteinase-9, and tissue inhibitor of metalloproteinase-1 in transitional cell carcinoma of upper urinary tract: correlation with tumor stage and survival.
    Miyata Y, Kanda S, Nomata K, Hayashida Y, Kanetake H.
    Urology; 2004 Mar 15; 63(3):602-8. PubMed ID: 15028476
    [Abstract] [Full Text] [Related]

  • 17. Transitional cell carcinoma of the renal pelvis or ureter: patterns of failure.
    Cozad SC, Smalley SR, Austenfeld M, Noble M, Jennings S, Raymond R.
    Urology; 1995 Dec 15; 46(6):796-800. PubMed ID: 7502418
    [Abstract] [Full Text] [Related]

  • 18. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.
    Yu RJ, Stein JP, Cai J, Miranda G, Groshen S, Skinner DG.
    J Urol; 2006 Aug 15; 176(2):493-8; discussion 498-9. PubMed ID: 16813876
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Transitional cell carcinomas of the renal pelvis and the ureter: comparative demographic characteristics, pathological grade and stage and 5-year survival in a Taiwanese population.
    Tan LB, Chang LL, Cheng KI, Huang CH, Kwan AL.
    BJU Int; 2009 Feb 15; 103(3):312-6. PubMed ID: 18782312
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.